BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26

• FDA

  Talecris Biotherapeutics Receives Health Canada Approval for PROLASTIN(R)-C

  February 18, 2010

   · 

  1 min read
• Pharm Country

  Preliminary Data from Roche Molecular Systems, Inc. ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping

  February 18, 2010

   · 

  1 min read
• Business

  Notice of Paladin Labs Inc.'s 2009 Fourth Quarter Results Conference Call

  February 18, 2010

   · 

  2 min read
• Business

  Cornerstone Therapeutics Inc. to Host Fourth Quarter and Full-Year 2009 Conference Call

  February 18, 2010

   · 

  2 min read
• Business

  Solvay SA : Operating Result In The Fourth Quarter (EUR 313 Million) Clearly Improved Compared To Last Year (EUR 125 Million) In Every Sector Of Activity; For The Year Overall, The Decrease Was Limited To 6%

  February 18, 2010

   · 

  25 min read
• Business

  RiskMetrics and Glass Lewis Support Nabi Biopharmaceuticals’ Proposed NicVAX Option and License Agreement

  February 18, 2010

   · 

  1 min read
• Pharm Country

  Discovery Laboratories Prices $16.5 Million Public Offering of Common Stock and Warrants

  February 18, 2010

   · 

  1 min read
• BioMidwest

  Aastrom Biosciences, Inc. One-for-Eight Reverse Stock Split Now Effective

  February 18, 2010

   · 

  1 min read
• Business

  ev3 Inc. Reports 2009 Fourth Quarter and Full-Year Financial Results and 2010 Guidance

  February 18, 2010

   · 

  1 min read
• Business

  Martek Biosciences Corporation to Host Investor Day on March 5, 2010

  February 18, 2010

   · 

  1 min read